However, in patients with IBD, as barrier function is impaired, TLR signaling is hyperactivated and, consequently, the expression of TNF-α and IL-1, IL-2, IL-6, and IL-12 is elevated [34,50]. The gene discussed is IL6; the disease is inflammatory bowel disease.